Category: Healthcare

  • Proton Pump Inhibitors Market

    —

    by

    The global proton pump inhibitors (PPIs) market is projected to achieve a valuation of US$ 4.0 billion in 2024, expanding at a revised CAGR of 6.2%, and is expected to surpass US$ 6.4 billion by 2034.

  • Psoriatic Arthritis (PsA) Treatment Market

    —

    by

    The global Psoriatic Arthritis (PsA) treatment market is projected to experience significant growth, with an estimated market value of USD 12,973.7 million in 2024, reaching USD 26,375.6 million by 2034. This corresponds to a robust compound annual growth rate (CAGR) of 8.8% over the forecast period.

  • Psychosis Diagnostics Market

    —

    by

    The Psychosis Diagnostics Market is experiencing significant growth, fueled by increasing awareness of mental health disorders, advancements in diagnostic technologies, and rising demand for precision medicine. The market is projected to be valued at US$ 3.15 billion in 2025, reaching US$ 4.6 billion by 2035, expanding at a CAGR of 6.3% over the forecast period.

  • Psychotropic Drugs Market

    —

    by

    The Psychotropic Drugs Market is poised for consistent growth, fueled by the rising prevalence of mental health disorders, increasing societal awareness, and advancements in drug formulations. The global market is projected to reach US$ 22,269.4 million in 2025, expanding at a CAGR of 4.1%, and is expected to surpass US$ 29,876.2 million by 2035.

  • Pulmonary Arterial Hypertension Treatment Market

    —

    by

    The Pulmonary Arterial Hypertension (PAH) Treatment Market is projected to experience substantial growth, with an estimated valuation of US$ 6,811.5 million in 2025, surging to US$ 8,224.4 million by 2035. The market is set to expand at a CAGR of 3.2% during the forecast period

  • Pulmonary Fibrosis Biomarker Market

    —

    by

    The global pulmonary fibrosis biomarker market is projected to achieve a valuation of US$ 4.4 billion in 2024, growing at a revised CAGR of 5.4%, to reach approximately US$ 7.5 billion by 2034.

  • Pulmonary Function Testing Device Market

    —

    by

    The global pulmonary function testing device market is projected to reach US$ 168.3 million by 2025, expanding at a CAGR of 5.8% over the forecast period.

  • Pulmonology Devices Market

    —

    by

    The global Pulmonology Devices Market is set to witness robust growth, with a projected valuation of US$ 2.4 billion in 2025, soaring to US$ 4.8 billion by 2035. The market is expected to grow at a CAGR of 11.3% during the forecast period

  • Pulse Electromagnetic Field Therapy Devices Market

    —

    by

    The Pulse Electromagnetic Field (PEMF) Therapy Devices Market is set for substantial expansion, with an estimated valuation of US$ 553.4 million in 2025, reaching US$ 1.2 billion by 2035.

  • Pulsed Field Ablation Market

    —

    by

    The global pulsed field ablation (PFA) market is projected to reach US$ 2.3 million by 2025, expanding at a CAGR of 25.2% over the forecast period.